Hasara Garrison J.
Insider CIK 1510349 · HPPI CFO and Treasurer · ABPI Acting Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| INTI Inhibitor Therapeutics, In | A Award deriv | 2020-12-22 | 2020-12-28 | 125,000 | — | $0 | 125,000 | SEC↗ |
| INTI Inhibitor Therapeutics, In | A Award deriv | 2020-09-17 | 2020-09-21 | 100,000 | — | $0 | 100,000 | SEC↗ |
| INTI Inhibitor Therapeutics, In | P Buy | 2019-12-02 | 2019-12-02 | 13,500 | $0.07 | $945 | 3,972,544 | SEC↗ |
| HPPI HedgePath Pharmaceuticals, | S Sale | 2018-08-30 | 2018-08-31 | 100,000 | $0.27 | $27.0K | 3,959,044 | SEC↗ |
| HPPI HedgePath Pharmaceuticals, | A Award deriv | 2018-03-13 | 2018-03-15 | 260,000 | — | $0 | 260,000 | SEC↗ |
| HPPI HedgePath Pharmaceuticals, | M Exercise deriv | 2017-03-08 | 2017-03-10 | 3,500,000 | — | $0 | 0 | SEC↗ |
| HPPI HedgePath Pharmaceuticals, | M Exercise deriv | 2017-03-08 | 2017-03-10 | 3,500,000 | — | $0 | 0 | SEC↗ |
| HPPI HedgePath Pharmaceuticals, | F Tax w/h | 2017-03-08 | 2017-03-10 | 1,470,478 | $0.34 | $500.0K | 2,029,522 | SEC↗ |
| HPPI HedgePath Pharmaceuticals, | M Exercise | 2017-03-08 | 2017-03-10 | 3,500,000 | — | $0 | 5,529,522 | SEC↗ |
| HPPI HedgePath Pharmaceuticals, | F Tax w/h | 2017-03-08 | 2017-03-10 | 1,470,478 | $0.34 | $500.0K | 4,059,044 | SEC↗ |
| HPPI HedgePath Pharmaceuticals, | M Exercise | 2017-03-08 | 2017-03-10 | 3,500,000 | — | $0 | 3,500,000 | SEC↗ |
| ABPI ACCENTIA BIOPHARMACEUTICAL | A Award deriv | 2012-08-24 | 2012-09-14 | 109,654 | — | $0 | 109,654 | SEC↗ |
| ABPI ACCENTIA BIOPHARMACEUTICAL | A Award deriv | 2012-02-29 | 2012-03-02 | 100,000 | — | $0 | 100,000 | SEC↗ |